Gabelli Funds’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$278K Buy
8,410
+1,910
+29% +$63.1K ﹤0.01% 1100
2025
Q1
$261K Buy
6,500
+1,500
+30% +$60.3K ﹤0.01% 979
2024
Q4
$235K Sell
5,000
-400
-7% -$18.8K ﹤0.01% 1000
2024
Q3
$285K Buy
5,400
+400
+8% +$21.1K ﹤0.01% 965
2024
Q2
$271K Hold
5,000
﹤0.01% 958
2024
Q1
$351K Buy
+5,000
New +$351K ﹤0.01% 930